Schedule an Appointment

*Please fill in all the required fields.

Do you have an order from a physician and want to schedule an appointment?

YES

NO

In order to assure you are getting the test your physician requires, it is important that you have the order. Please contact your physician to obtain an order so you can be scheduled properly.

 

Aultman Wait Times

Choose Immediate Care for colds/flu, sprains/strains and other minor injury/illness.


Go to the ER for major concerns and trauma. Call 911 for chest pain and stroke symptoms.

Menu

Medical Services

Support Services

location icon

Location Finder

Here's your guide to finding any of the facilities in the Aultman family of health services, including maps and contacts. 

symptom checker icon

Need a Doctor?

Aultman Medical Group's network of more than 240 providers is committed to high-level patient care.

calendar icon

Schedule an Appointment

Click below to complete an online form. 

 

donation icon

Donate Today

You can help support and enhance services, and in turn, help patients and their families who benefit from care received at Aultman.

Lung Cancer

Below are the most current lung cancer trials Aultman has to offer. To learn more about a specific trial, please click the the trial number below the trial sponsor in the table below.

Trial Sponsor

Study Type

     Condition

Intervention Type

National Cancer Institute
A151216
ALCHEMIST

Genetic

Stage IB, II, or IIIA non-small cell lung cancer

Genetic marker identification and matching to available treatment studies

National Cancer Institute
A081801
(ALCHEMIST Sub-study)

Treatment
Phase 3

Stage IB, II, IIA, IIB, IIIA Non-small Cell Lung Cancer treated with surgery

Pembrolizumab as add on therapy to standard chemotherapy

National Cancer Institute
LUNGMAP

Genetic

Stage IV or recurrent non-small cell lung cancer

Genetic marker identification and matching to available treatment studies

National Cancer Institute
S1900E
(LUNGMAP SUB STUDY)

Interventional
Phase 2

Stage IV non-small cell lung cancer

AMG510

National Cancer Institute
E4512
(Sub-part to ALCHEMIST)

Treatment
Phase 3

Stage IB, IIA, IIB, IIIA Non-small Cell Lung Cancer treated with surgery

Crizotinib vs. placebo for tumors with ALK protein

University of Nebraska
iCaRe2

Registry

Lung Cancer (any stage/type)

Risk factor questionnaire

NovoCure Ltd.

KEYNOTE B-36

(TTFields)

Interventional

Advanced or Metastatic Intrathoracic on-small Cell Lung Cancer

Pembrolizumab and TTFields

National Cancer Institute
S2302

Treatment
Phase 3

Stage IV or Recurrent Non-Small Cell Lung Cancer

Ramucirumab Plus Pembrolizumab vs Usual Care

Tempus
Gemini NSCLC

Observational

A Longitudinal Circulating Tumor DNA (ctDNA) Biomarker Profiling Study of Patients with Non-Small Cell Lung Cancer (NSCLC) Using Comprehensive Next-Generation Sequencing (NGS) Assays

Biomarker Profiling Study

AstraZeneca
Avanzar (D926NC00001)

Treatment
Phase 3

Locally Advanced or Metastatic NSCLC Without Actionable Genomic Alterations

Datopotamab Deruxtecan (Dato-DXd) in Combination With Durvalumab and Carboplatin

National Cancer Institute
S1900G

Treatment
Phase II Study

EGFR-Mutant, MET-Amplified Stage IV or Recurrent Non-Small Cell Lung Cancer

Comparing Combinations of Targeted Drugs

National Cancer Institute
LU007

Treatment
Phase II/III Study

Extensive Stage-Small Cell Lung Cancer 

Addition of Radiation Therapy to the Usual Immune Therapy Treatment (Atezolizumab)

National Cancer Institute
EAY191 S3

Treatment
Phase 2

AKT-Altered Advanced Non-Breast Solid Tumors

Paclitaxel plus Ipatasertib

Henlius Biotech Inc.
HLX10-005-SCLC301-E [ASTRIDE]

Treatment
Phase 3

Extensive Stage Small Cell Lung Cancer (ES-SCLC)

HLX10 (Recombinant Humanized Anti-PD-1 Monoclonal Antibody Injection) in Combination With Chemotherapy (Carboplatin-Etoposide)

National Cancer Institute
EA5221

Treatment
Phase 3

A Randomized Phase III Trial of Chemo-Immunotherapy vs Immunotherapy Alone for the Vulnerable Older Adult with Advanced Non-Small Cell Lung Cancer: The ACHIEVE Study  

Pembrolizumab

vs

Pembrolizumab with chemotherapy

location icon

Location Finder

Here's your guide to finding any of the facilities in the Aultman family of health services, including maps and contacts. 

symptom checker icon

Need a Doctor?

Aultman Medical Group's network of more than 240 providers is committed to high-level patient care.

calendar icon

Schedule an Appointment

Click below to complete an online form. 

 

donation icon

Donate Today

You can help support and enhance services, and in turn, help patients and their families who benefit from care received at Aultman.

What's Happening